SCORing Atopic Dermatitis (SCORAD)
The SCORAD index is a clinical tool to assess both the severity and extent of eczema. There are 3 components of the tool, including the area affected, intensity of eczema, and the subjective symptoms of the patient. The SCORAD index may be used by healthcare professionals (HCPs) before and after treatment to determine if the treatment is effective. The SCORAD has been validated for use in AD patients of all ages.
Please record your patient’s AD symptoms using the following tool:
Area affected (A)
Assessed by shading on a drawing of the body
Head and neck
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Upper limbs (left)
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Upper limbs (right)
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Lower limbs (left)
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Lower limbs (right)
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Anterior trunk
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Back
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Genitals
Please select a range
  • 0%
  • 25%
  • 50%
  • 75%
  • 100%
Intensity (B)
Erythema
Please select a range
  • None
  • Mild
  • Moderate
  • Severe
Edema or papulation
Please select a range
  • None
  • Mild
  • Moderate
  • Severe
Oozing or crusting
Please select a range
  • None
  • Mild
  • Moderate
  • Severe
Excoriations
Please select a range
  • None
  • Mild
  • Moderate
  • Severe
Lichenification
Please select a range
  • None
  • Mild
  • Moderate
  • Severe
Dryness
Please select a range
  • None
  • Mild
  • Moderate
  • Severe
Subjective symptoms (C)
Less severe: 0; more severe: 10
Pruritus
Please select a range
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Sleep loss
Please select a range
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Result
Sub-scores
Area affected (A):
Total intensity (B):
Subjective symptom (C):
Total score:
Classified as mild AD moderate AD severe AD
Total Score
≤25
25-50
>50
AD status
Mild
Moderate
Severe
Score breakdown :
Area affected (A)
Area
 
Score
Head and neck:
None
0
Upper limbs (left):
None
0
Upper limbs (right):
None
0
Lower limbs (left):
None
0
Lower limbs (right):
None
0
Anterior trunk:
None
0
Back:
None
0
Genitals:
None
0
Intensity (B)
Symptoms
Severity
Score
Erythema:
None
0
Edema or papulation:
None
0
Oozing or crusting:
None
0
Excoriations:
None
0
Lichenification:
None
0
Dryness:
None
0
Subjective symptoms (C)
Less severe: 0; more severe: 10
Symptoms
Severity
Score
Pruritis
None
0
Sleep loss
None
0
Scoring Principle :

The final score is processed as listed below using an index formula of 0.2A + 3.5B + C.

Area affected (A)

The initial score is scaled by the rule of 9, and the final percentage is converted 1:1 to the area affected score:

  • Head and neck =9%
  • Upper limbs (left) =9%
  • Upper limbs (right) =9%
  • Lower limbs (left) =18%
  • Lower limbs (right) =18%
  • Anterior trunk =18%
  • Back =18%
  • Genitals =1%
Intensity (B)

Intensity is scored in a representative area of AD. Each criterion is scored between 0-3 points from none to severe.

Subjective symptoms (C)

Daily subjective symptoms including pruritis and sleep loss are reported by patients using a 10-cm visual analogue scale.

If you are concerned that your eczema may not be well controlled, please seek medical advice. Bring your completed test results with you at your next scheduled consultation and speak to your doctor with the help of the test results to describe how your eczema is affecting you.

Download the report

All submitted data were anonymized and not kept for record. Feel free to use the information to assess your atopic dermatitis status.

References:

  1. SCORing Atopic Dermatitis (SCORAD) Calculator (0.9.0). Sanofi. Available at: https://rb.gy/vbeqjo Accessed on: February 28, 2023.
  2. SCORAD. DermNet. Available at: https://rb.gy/mcgiiu. Accessed on: February 28, 2023.

Dear visitor,

Thank you for using the atopic dermatitis (AD) assessment tool provided by EczemaSchool. Your SCORAD results have been summarized below.

Sub-scores
Area affected (A):
Total intensity (B):
Subjective symptom (C):
Total score:
Classified as mild AD moderate AD severe AD
Area affected (A)
Area
 
Score
Head and neck:
None
0
Upper limbs (left):
None
0
Upper limbs (right):
None
0
Lower limbs (left):
None
0
Lower limbs (right):
None
0
Anterior trunk:
None
0
Back:
None
0
Genitals:
None
0
Intensity (B)
Symptoms
Severity
Score
Erythema:
None
0
Oozing or crusting:
None
0
Excoriations:
None
0
Lichenification:
None
0
Dryness:
None
0
Subjective symptoms (C)
Less severe: 0; more severe: 10
Symptoms
Severity
Score
Pruritis
None
0
Sleep loss
None
0
Scoring Principle :

The final score is processed as listed below using an index formula of 0.2A + 3.5B + C.

Area affected (A)

The initial score is scaled by the rule of 9, and the final percentage is converted 1:1 to the area affected score:

  • Head and neck =9%
  • Upper limbs (left) =9%
  • Upper limbs (right) =9%
  • Lower limbs (left) =18%
  • Lower limbs (right) =18%
  • Anterior trunk =18%
  • Back =18%
  • Genitals =1%
Intensity (B)

Intensity is scored in a representative area of AD. Each criterion is scored between 0-3 points from none to severe.

Subjective symptoms (C)

Daily subjective symptoms including pruritis and sleep loss are reported by patients using a 10-cm visual analogue scale.

If you are concerned that your eczema may not be well controlled, please seek medical advice. Bring your completed test results with you at your next scheduled consultation and speak to your doctor with the help of the test results to describe how your eczema is affecting you.

All submitted data were anonymized and not kept for record. Feel free to use the information to assess your atopic dermatitis status.

References:

  1. SCORing Atopic Dermatitis (SCORAD) Calculator (0.9.0). Sanofi. Available at: https://rb.gy/vbeqjo Accessed on: February 28, 2023.
  2. SCORAD. DermNet. Available at: https://rb.gy/mcgiiu. Accessed on: February 28, 2023.

© EczemaSchool - All rights reserved